Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015–2016

[1]  P. Vedsted,et al.  Ovarian cancer suspicion, urgent referral and time to diagnosis in Danish general practice: a population-based study. , 2019, Family practice.

[2]  A. Gavin,et al.  Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP) , 2019, BMJ Open.

[3]  B. Naume,et al.  Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway. , 2019, Cancer epidemiology.

[4]  A. Gavin,et al.  Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP) , 2018, BMJ Open.

[5]  B. Møller,et al.  Stage-specific incidence and survival of breast cancer in Norway: The implications of changes in coding and classification practice. , 2018, Breast.

[6]  Melissa Matz,et al.  Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.

[7]  Publisher's Note , 2018, Anaesthesia.

[8]  P. Vedsted,et al.  Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care , 2017, BMC Cancer.

[9]  H. Thulesius,et al.  The 2015 National Cancer Program in Sweden: Introducing standardized care pathways in a decentralized system. , 2016, Health policy.

[10]  J. Overgaard,et al.  Tumour stage and implementation of standardised cancer patient pathways: a comparative cohort study. , 2016, The British journal of general practice : the journal of the Royal College of General Practitioners.

[11]  F. Bray,et al.  Regional variations in cancer survival: Impact of tumour stage, socioeconomic status, comorbidity and type of treatment in Norway , 2016, International journal of cancer.

[12]  B. Møller,et al.  Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage , 2016, International journal of cancer.

[13]  B. Møller,et al.  Utilizing national patient-register data to control for comorbidity in prognostic studies , 2014, Clinical epidemiology.

[14]  J. Overgaard,et al.  Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study , 2014, BMC Cancer.

[15]  O C Ukoumunne,et al.  Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database , 2013, British Journal of Cancer.

[16]  C. Bünger,et al.  Cancer Patient Pathways shortens waiting times and accelerates the diagnostic process of suspected sarcoma patients in Denmark. , 2013, Health Policy.

[17]  Helene Bilsted Probst,et al.  Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians--a national Danish project. , 2012, Health policy.

[18]  Frede Olesen,et al.  Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients , 2011, BMC health services research.

[19]  J. Borrás,et al.  Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study , 2011, British Journal of Cancer.

[20]  F Olesen,et al.  Delay in diagnosis: the experience in Denmark , 2009, British Journal of Cancer.

[21]  Bjørn Møller,et al.  Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. , 2009, European journal of cancer.

[22]  Arild Nesbakken,et al.  Kirurgisk behandling av tykktarmskreft , 2007 .

[23]  B. Leese,et al.  Urgent GP referrals for suspected lung, colorectal, prostate and ovarian cancer. , 2006, The British journal of general practice : the journal of the Royal College of General Practitioners.

[24]  D. Rothenberger,et al.  Surgical treatment of colon cancer. , 2006, Surgical oncology clinics of North America.

[25]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[26]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.